L. Barnes et al., SALIVARY DUCT CARCINOMA .1. A CLINICOPATHOLOGICAL EVALUATION AND DNA IMAGE-ANALYSIS OF 13 CASES WITH REVIEW OF THE LITERATURE, Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 78(1), 1994, pp. 64-73
Citations number
38
Categorie Soggetti
Pathology,Surgery,"Dentistry,Oral Surgery & Medicine
Salivary duct carcinoma is an uncommon and relatively unknown clinical
ly aggressive adenocarcinoma of salivary origin that histologically de
monstrates a remarkable resemblance to invasive carcinoma of the breas
t. We report the clinicopathologic features of 13 cases that were also
examined by image analysis for DNA ploidy. The results were then anal
yzed collectively with the less than 100 cases of salivary duct carcin
oma reported in the English-language literature to define the characte
ristics of this unusual neoplasm. The 12 men and one woman averaged 68
years of age (range, 49 to 90 years). All tumors arose in the parotid
(10 cases) or submandibular glands (three cases). Nine tumors were an
euploid, three diploid, and one was indeterminate because of insuffici
ent tissue. Follow-up (median, 24 months) was available in 12 cases: t
hree patients cried of disease, six were alive without disease, and th
ree died of other causes. Combining our cases with those in the litera
ture, a total of 104 cases, confirms that salivary duct carcinoma is a
highly malignant neoplasm with distinctive clinical and pathologic fe
atures. It arises almost exclusively in the major salivary glands (96%
of cases), is three times more common in men, and usually occurs in p
atients over 50 years of age (range, 22 to 91 years). One-third of pat
ients experience local recurrences, 59% develop positive regional lymp
h nodes, 46% have systemic metastases (lungs and bones), and 65% die o
f their disease, usually within 4 years of diagnosis. Determination of
tumor ploidy has no prognostic significance. The presence of distant
metastasis was the only clinicopathologic feature that was statistical
ly associated with prognosis (p = 0.02); all patients with systemic me
tastasis died of disease.